Patent details
EP2435068 Title: USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY
Basic Information
- Publication number:
- EP2435068
- PCT Application Number:
- PCT/US/2010/036615
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107812901
- PCT Publication Number:
- WO/2010/138839
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY
- French Title of Invention:
- UTILISATION DE 2 ANTICORPS ANTI-SPARC EN VUE DE PRÉVOIR LA RÉACTION À UNE CHIMIOTHÉRAPIE
- German Title of Invention:
- VERWENDUNG VON 2 SPARC-ANTIKÖRPERN ZUR VORHERSAGE DES ANSPRECHENS AUF EINE CHEMOTHERAPIE
- SPC Number:
Dates
- Filing date:
- 28/05/2010
- Grant date:
- 04/03/2015
- EP Publication Date:
- 04/03/2015
- PCT Publication Date:
- 02/12/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/04/2012
- EP B1 Publication Date:
- 04/03/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/05/2015
- Expiration date:
- 28/05/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/05/2010
- Name:
- Abraxis BioScience LLC
- Address:
- 11755 Wilshire Boulevard Suite 2000, Los Angeles, CA 90025, United States (US)
Inventor
1
- Name:
- DESAI Neil
- Address:
- United States (US)
2
- Name:
- KNAUER Daniel
- Address:
- United States (US)
3
- Name:
- TRIEU Vuong
- Address:
- United States (US)
Priority
- Priority Number:
- 182081 P
- Priority Date:
- 28/05/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/20;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|